Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment.

PubWeight™: 1.89‹?› | Rank: Top 3%

🔗 View Article (PMID 10513647)

Published in AIDS on October 01, 1999

Authors

V Tozzi1, P Balestra, S Galgani, P Narciso, F Ferri, G Sebastiani, C D'Amato, C Affricano, F Pigorini, F M Pau, A De Felici, A Benedetto

Author Affiliations

1: Department of Infectious Diseases, IRCCS Lazzaro Spallanzani, Rome, Italy.

Articles citing this

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32

Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology (2002) 4.67

Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev (2009) 2.86

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology (2010) 2.40

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis (2012) 1.31

Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav (2010) 1.29

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One (2014) 1.21

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. PLoS One (2014) 1.12

HIV and HIV dementia. J Clin Invest (2000) 1.10

Better quality of life with neuropsychological improvement on HAART. Health Qual Life Outcomes (2006) 1.08

Controversies in HIV-associated neurocognitive disorders. Lancet Neurol (2014) 1.07

Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon. J Neurol Sci (2009) 1.07

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder. Clin Infect Dis (2013) 1.05

Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study. BMC Infect Dis (2013) 1.00

Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. J Neuroimmune Pharmacol (2013) 0.98

The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients. AIDS Patient Care STDS (2009) 0.94

Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru. AIDS Care (2014) 0.93

Impact of short-term combined antiretroviral therapy on brain virus burden in simian immunodeficiency virus-infected and CD8+ lymphocyte-depleted rhesus macaques. Am J Pathol (2010) 0.92

Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning. J Clin Exp Neuropsychol (2012) 0.89

4-Aminopyridine improves spatial memory in a murine model of HIV-1 encephalitis. J Neuroimmune Pharmacol (2009) 0.89

Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial. PLoS Clin Trials (2007) 0.89

Second assessment of NeuroAIDS in Africa. J Neurovirol (2008) 0.84

Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length. PLoS One (2014) 0.83

Abnormal contingent negative variation in HIV patients receiving antiretroviral therapy. Neuroreport (2003) 0.83

Voltage-gated potassium channels in human immunodeficiency virus type-1 (HIV-1)-associated neurocognitive disorders. J Neuroimmune Pharmacol (2008) 0.83

Neuropsychological test performance before and after HIV-1 seroconversion: the Multicenter AIDS Cohort Study. J Neurovirol (2012) 0.83

Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection. J Neurovirol (2008) 0.82

Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci (2011) 0.81

Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients. J Clin Exp Neuropsychol (2010) 0.79

Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. J Neurovirol (2013) 0.78

The role of tau protein in HIV-associated neurocognitive disorders. Mol Neurodegener (2014) 0.76

Topographies of Cortical and Subcortical Volume Loss in HIV and Aging in the cART Era. J Acquir Immune Defic Syndr (2016) 0.76

Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease. Front Microbiol (2016) 0.76

Lower CSF Aβ is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. Curr HIV Res (2016) 0.76

Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview. Front Microbiol (2016) 0.75

Selective developmental alterations in The HIV-1 transgenic rat: Opportunities for diagnosis of pediatric HIV-1. J Neurovirol (2016) 0.75

Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts. Neuroradiol J (2015) 0.75

Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals. J Acquir Immune Defic Syndr (2014) 0.75

Neuropsychological evaluation and follow up in jcv- and non-jcv-related leukoencephalopathies in HIV infection. Neurol Sci (2011) 0.75

Articles by these authors

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS (2000) 4.55

The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med (1995) 3.86

Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83

Fault lubrication during earthquakes. Nature (2011) 2.28

Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J Virol (1998) 1.99

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol (1999) 1.65

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Incisional hernia and fascial defect following laparoscopic surgery. Surg Laparosc Endosc Percutan Tech (2000) 1.56

Inhibition of virus protein glycosylation as the mechanism of the antiviral action of prostaglandin A in Sendai virus-infected cells. J Gen Virol (1989) 1.54

Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women. HIV Med (2006) 1.43

Prevalence of hepatitis B and C viruses and human immunodeficiency virus infections in women of reproductive age. Br J Obstet Gynaecol (1992) 1.41

Cytomegalovirus encephalitis in two patients with AIDS receiving ganciclovir for cytomegalovirus retinitis. J Infect (1994) 1.41

A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia (2012) 1.35

Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr (2001) 1.24

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

NMDA receptor losses in putamen from patients with Huntington's disease. Science (1988) 1.21

In situ measurements of the physical characteristics of Titan's environment. Nature (2005) 1.20

Neural correlates of worry in generalized anxiety disorder and in normal controls: a functional MRI study. Psychol Med (2009) 1.20

Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19

Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76  TeV. Phys Rev Lett (2012) 1.19

Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS (2003) 1.17

Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations. J Med Virol (2001) 1.14

Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase. AIDS Res Hum Retroviruses (1996) 1.14

Prostaglandin A compounds as antiviral agents. Science (1980) 1.13

Erythropoietin therapy and preoperative autologous blood donation in children undergoing open heart surgery. Br J Anaesth (2001) 1.12

Neuropathological correlates of dysarthria in progressive supranuclear palsy. Arch Neurol (2001) 1.12

Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS (2004) 1.12

Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7  TeV. Phys Rev Lett (2012) 1.10

Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study. Acta Psychiatr Scand (2002) 1.09

Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09

Inhibition of animal virus production by means of translation inhibitors unable to penetrate normal cells. Virology (1980) 1.08

Population exposure to electromagnetic fields generated by radio base stations: evaluation of the urban background by using provisional model and instrumental measurements. Radiat Prot Dosimetry (2001) 1.08

Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08

Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07

Analysis of co-receptor usage of circulating viral and proviral HIV genome quasispecies by ultra-deep pyrosequencing in patients who are candidates for CCR5 antagonist treatment. Clin Microbiol Infect (2010) 1.06

Fast multi-tau real-time software correlator for dynamic light scattering. Appl Opt (2001) 1.06

Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05

n-Hexane-induced changes in nerve conduction velocities and somatosensory evoked potentials. Int Arch Occup Environ Health (1982) 1.04

Resistance to salmonellosis in the chicken is linked to NRAMP1 and TNC. Genome Res (1997) 1.04

Hepatitis C virus infection in intravenous drug users: prevalence and risk factors. Scand J Infect Dis (1990) 1.02

gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy. Immunology (2000) 1.02

Incidence of malignancies in HIV-infected patients and prognostic role of current CD4 cell count: evidence from a large Italian cohort study. Clin Infect Dis (2010) 1.02

A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Ann Neurol (1993) 1.01

Seasonal photoperiodism regulates the expression of cuticular and signalling protein genes in the pea aphid. Insect Biochem Mol Biol (2007) 1.01

Cor triatriatum. Clinical presentation and operative results. J Thorac Cardiovasc Surg (1991) 1.01

An unusual intra-articular ganglion of the knee with interosseous extension. A case report. J Bone Joint Surg Am (1989) 1.00

IL-12-mediated NKRP1A up-regulation and consequent enhancement of endothelial transmigration of V delta 2+ TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients. J Immunol (1999) 1.00

Improving adherence to highly active anti-retroviral therapy in Africa: the DREAM programme in Mozambique. Health Educ Res (2005) 1.00

[Study on the diffusion of influenza in the Roman population during the October 1972-May 1973 period]. Nuovi Ann Ig Microbiol (1974) 1.00

Images of asteroid 21 Lutetia: a remnant planetesimal from the early Solar System. Science (2011) 0.99

Dynamics of viral load in plasma and HIV DNA in lymphocytes during highly active antiretroviral therapy (HAART): high viral burden in macrophages after 1 year of treatment. J Chemother (2001) 0.99

Inhibition of transcription and translation of globin messenger RNA in dimethyl sulfoxide-stimulated Friend erythroleukemic cells treated with interferon. Proc Natl Acad Sci U S A (1977) 0.99

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.99

Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99

A high-resolution map in the chromosomal region surrounding the Lps locus. Genomics (1996) 0.99

A case of dengue type 3 virus infection imported from Africa to Italy, October 2009. Euro Surveill (2010) 0.98

Male-to-female transmission of human immunodeficiency virus infection by oro-genital sex. Eur J Clin Microbiol Infect Dis (1991) 0.98

Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98

Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97

HIV-particles in spermatozoa of patients with AIDS and their transfer into the oocyte. J Cell Biol (1994) 0.95

Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2013) 0.95

[Acute rhabdomyolysis as a result of body-building]. Recenti Prog Med (1987) 0.95

Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy. Phys Rev Lett (2012) 0.95

Pattern of therapeutic intervention and role of psychiatric settings: a survey in two regions of Italy. Acta Psychiatr Scand (1987) 0.95

Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med (2012) 0.94

P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. Electroencephalogr Clin Neurophysiol (1991) 0.94

p16(INK4A) expression is related to grade of cin and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol (2004) 0.93

Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. II. Changes in cell surface glycoproteins associated with a highly malignant phenotype. Int J Cancer (1984) 0.92

Experiences in pancreas scanning using 75-Se-selenomethionine. Br J Radiol (1967) 0.92

Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancer. Eur J Obstet Gynecol Reprod Biol (2006) 0.92

Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function. Clin Exp Immunol (2012) 0.92

37RC cells rapidly recover their RNA synthesis after inhibition with high doses of actinomycin D. J Cell Biol (1972) 0.92

Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet Med (2009) 0.91

Creutzfeldt-Jakob disease after non-commercial dura mater graft. Lancet (1992) 0.91

Modulation of the growth of a human erythroleukemic cell line (K562) by prostaglandins: antiproliferative action of prostaglandin A. Cancer Res (1986) 0.91

Effects of zidovudine in 30 patients with mild to end-stage AIDS dementia complex. AIDS (1993) 0.91

Gasless laparoscopic-assisted ileostomy or colostomy closure using an abdominal wall-lifting device. Surg Endosc (2001) 0.91

[Tuberculosis-associated immune reconstitution inflammatory syndrome]. Infez Med (2008) 0.91

Role of human immunodeficiency virus in primary pulmonary hypertension--case reports. Angiology (1998) 0.91

First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91

Determinants of squamous intraepithelial lesions (SIL) on Pap smear: the role of HPV infection and of HIV-1-induced immunosuppression. DIANAIDS Collaborative Study Group. Eur J Epidemiol (1997) 0.90

Acute disseminated encephalomyelitis as manifestation of primary HIV infection. Neurology (2001) 0.90

Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study. Eur J Gynaecol Oncol (2004) 0.90

Detection of cytomegalovirus-matrix protein (pp65) in leukocytes of HIV-infected patients with painful peripheral neuropathy. J Med Virol (1994) 0.90

Polymerization of rod-like macromolecular monomers studied by stopped-flow, multiangle light scattering: set-up, data processing, and application to fibrin formation. Biophys J (2000) 0.90

Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART. J Infect (2001) 0.90

Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2001) 0.90

Search for supersymmetry in pp collisions at √7 TeV in events with two photons and missing transverse energy. Phys Rev Lett (2011) 0.90